$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical News
Medical News
How much will Osimertinib cost after price reduction in 2021? Osimertinib price in 2021
2025-10-19 11:44:20
Check Details
Osimertinib 2021 medical insurance price, osimertinib 2021 rural insurance reimbursement policy
2025-10-19 11:44:20
Check Details
The latest price of cabozantinib in 2021. Is cabozantinib expensive?
2025-10-19 11:44:20
Check Details
How much does cabozantinib cost?
2025-10-19 11:44:20
Check Details
FDA approves lorlatinib for first-line treatment of ALK-positive metastatic lung cancer_Canghule
2025-10-19 11:44:20
Check Details
Rybrevant Instructions, Rybrevant Indications, Usage and Dosage
2025-10-19 11:44:20
Check Details
Has Rybrevant, a targeted therapy for mutant lung cancer, been approved by the FDA?
2025-10-19 11:44:20
Check Details
What is the effect of Rybrevant, the first targeted therapy for difficult-to-treat lung cancer?
2025-10-19 11:44:20
Check Details
Rybrevant targeted drug, the latest lung cancer drug approved for marketing?
2025-10-19 11:44:20
Check Details
When will Lumakras (sotorasib) be available in China? What disease is treated?
2025-10-19 11:44:20
Check Details
What kind of people are suitable for using Lumakras? What are the precautions for using Lumakras
2025-10-19 11:44:20
Check Details
[News Flash] Lumakras, the first KRAS-targeting drug for lung cancer, is approved by the FDA for marketing
2025-10-19 11:44:20
Check Details
1
2
...
9986
9987
9988
9989
9990
9991
9992
...
10204
10205
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
What diseases can Upatinib be used for? Which patients are suitable for use?
2
The efficacy of Eltrombopag
3
User Agreement
4
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
5
What is the most important information I should know about WELIREG?
6
How to take and store WELIREG
7
How to take TRUSELTIQ correctly
8
How to deal with LONSURF side effects (1)
9
How to deal with LONSURF side effects (2)
10
Cabozantinib (Cabometyx)-new indication approved
11
What should I pay attention to when using atezolizumab/Tecentriq?
12
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma